NAMS - NewAmsterdam Pharma Co N.V.
31.18
0.775 2.486%
Share volume: 883,667
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$30.40
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-08-2025 | 11-05-2025 | 02-18-2026 | |
| Total revenue | 1.401 M | 2.279 M | 29.111 M | 12.772 M | 2.978 M | 348.000 K | 32.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.401 M | 2.279 M | 29.111 M | 12.772 M | 2.978 M | 348.000 K | 32.000 K | |
| 62.67% | 1,177.36% | -56.13% | -76.68% | -88.31% | -90.80% | |||
| Operating expenses | 56.883 M | 54.854 M | 54.114 M | 56.001 M | 71.903 M | 55.491 M | 66.012 M | |
| Selling general and admin | 14.453 M | 16.475 M | 18.412 M | 21.106 M | 27.152 M | 24.520 M | 27.418 M | |
| Research and development | 42.430 M | 38.379 M | 35.702 M | 34.895 M | 44.751 M | 30.971 M | 38.594 M | |
| Total expenses | 56.883 M | 54.854 M | 54.114 M | 56.001 M | 71.903 M | 55.492 M | 66.011 M | |
| -3.57% | -1.35% | 3.49% | 28.40% | -22.82% | 18.96% | |||
| Operating income | -55.482 M | -52.575 M | -25.003 M | -43.229 M | -68.925 M | -55.143 M | -65.980 M | |
| Ebit | -96.850 M | -43.877 M | -21.091 M | -96.662 M | -46.878 M | -78.717 M | -81.397 M | |
| Pretax income | -93.767 M | -39.007 M | -16.648 M | -92.177 M | -39.527 M | -72.005 M | -74.923 M | |
| -58.40% | -57.32% | 453.68% | -57.12% | 82.17% | 4.05% | |||
| Income tax | 0.000 | 0.000 | -1.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -93.767 M | -39.007 M | -16.647 M | -92.177 M | -39.527 M | -72.005 M | -74.923 M | |
| 58.40% | 57.32% | -453.72% | 57.12% | -82.17% | -4.05% |